Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Terumo ( (JP:4543) ) has shared an update.
Terumo Corporation reported a significant increase in its non-consolidated financial results for FY2024 compared to FY2023, with notable growth in revenue, operating profit, ordinary profit, and net profit. The rise in ordinary and net profit was primarily driven by increased dividends received from its consolidated subsidiaries, indicating a strong financial performance and positive impact on stakeholders.
The most recent analyst rating on (JP:4543) stock is a Buy with a Yen3800.00 price target. To see the full list of analyst forecasts on Terumo stock, see the JP:4543 Stock Forecast page.
More about Terumo
Terumo Corporation is a Japanese company operating in the medical devices industry. It specializes in the development and manufacturing of medical products and equipment, focusing on areas such as cardiovascular systems, blood management, and hospital products.
Average Trading Volume: 3,782,173
Technical Sentiment Signal: Buy
Current Market Cap: Yen4087.6B
For detailed information about 4543 stock, go to TipRanks’ Stock Analysis page.